Anthony Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anthony Chan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Armel Stockis
UCB Pharma, Braine-l'Alleud, Belgium
1 shared publication - Barbara Peters
20 Clinical Trial Unit, University of Basel Basel, Switzerland
1 shared publication - Barry Hirst
University of Newcastle Newcastle, UK
1 shared publication - Behrouz Kassai
Hospices Civils de Lyon, EPICIME-CIC 1407 de Lyon, Inserm, Department of Clinical Epidemiology, CHU-Lyon, Bron, France
1 shared publication - Catherine Chiron
Necker-Enfants Malades Hospital
1 shared publication - Christiane Pauli-Magnus
19 University of Basel Basel, Switzerland
1 shared publication
Latest Publications
- Open Access
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 4, 112
A European approach to clinical investigator training
A better education and training of clinical investigators and their teams is one of the factors that could foster the development of clinical research in Europe, a key objective of the Innovative Medicines Initiative (IMI). PharmaTrain (an IMI programme on training in medicines development) and ECRIN (European Clinical Research Infrastructures Network) have joined forces to address this issue. An advisory group composed of representatives of universities, pharmaceutical companies and other organisations met four times between June 2011 and July 2012. This resulted in a position paper proposing a strategy to improve and harmonize clinical investigator training in Europe, and including a detailed syllabus and list of learning outcomes. Major recommendations are the establishment of minimal and mutually recognized certification requirement for investigators throughout the EU and the creation of a European platform to provide a suitable course and examination infrastructure.
- 1 January 2013
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 4, 112
Open AccessA European approach to clinical investigator training
A better education and training of clinical investigators and their teams is one of the factors that could foster the development of clinical research in Europe, a key objective of the Innovative Medicines Initiative (IMI). PharmaTrain (an IMI programme on training in medicines development) and ECRIN (European Clinical Research Infrastructures Network) have joined forces to address this issue. An advisory group composed of representatives of universities, pharmaceutical companies and other organisations met four times between June 2011 and July 2012. This resulted in a position paper proposing a strategy to improve and harmonize clinical investigator training in Europe, and including a detailed syllabus and list of learning outcomes. Major recommendations are the establishment of minimal and mutually recognized certification requirement for investigators throughout the EU and the creation of a European platform to provide a suitable course and examination infrastructure.